RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study (2018)
- Authors:
- Autor USP: SOUZA, ROGÉRIO DE - FM
- Unidade: FM
- DOI: 10.1007/s00408-018-0089-7
- Subjects: HIPERTENSÃO PULMONAR; IMAGEM POR RESSONÂNCIA MAGNÉTICA; DIAGNÓSTICO POR COMPUTADOR; VENTRÍCULO CARDÍACO
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
HOETTE, Susana e SOUZA, Rogerio. RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study. Lung, v. 196, n. 2, p. 157-164, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00408-018-0089-7. Acesso em: 13 fev. 2026. -
APA
Hoette, S., & Souza, R. (2018). RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study. Lung, 196( 2), 157-164. doi:10.1007/s00408-018-0089-7 -
NLM
Hoette S, Souza R. RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study [Internet]. Lung. 2018 ; 196( 2): 157-164.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1007/s00408-018-0089-7 -
Vancouver
Hoette S, Souza R. RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study [Internet]. Lung. 2018 ; 196( 2): 157-164.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1007/s00408-018-0089-7 - Incidência de hematomas subdurais espontâneos em casos de pacientes com hipertensão arterial pulmonar: Análise de um registro de cinco anos
- Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. [Carta]
- Pulmonary hypertension in sickle cell disease
- Challenging the concept of adding more drugs in pulmonary arterial hypertension [Editorial]
- Pulmonary arterialhHypertension-related morbidity is prognostic for mortality
- Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
- 2016 – Um segundo passo [Editorial]
- Building the Future of Trial Design in PAH on Solid Ground
- Goal-oriented treatment of pulmonary arterial hypertension
- Skeletal Muscle Abnormalities in Pulmonary Arterial Hypertension
Informações sobre o DOI: 10.1007/s00408-018-0089-7 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
